Wedbush Raises VeriSign Price Target to $367, No Earnings Trigger
Wedbush raised VeriSign's price target to $367 without an earnings revision, re-rating a .com domain monopoly that converts 47% of $1.7bn in revenue to free cash flow.
Wedbush Raises VeriSign Price Target to $367, No Earnings Trigger
NEW YORK, October 27 —
VeriSign, Inc. (VRSN) received a Wedbush price target increase to $367 on Monday, implying 19% upside from $308.72 with no earnings revision attached.
- PT raised to $367 vs. $308.72 current; rating maintained, no upgrade
- 28.2x fwd P/E on $9.21 trailing EPS; $800mn FCF on $1.7bn TTM revenue equals a 47% FCF margin
- Next quarterly earnings and net domain name registration count are the only catalyst that matters
No Earnings Revision Means Wedbush Is Buying the Multiple
Wedbush maintained its rating and attached no earnings revision or guidance update to the move. At 28.2x forward earnings, this is a statement about what VeriSign's monopoly income stream is worth in a falling-rate environment, not a bet that the income stream accelerates. The distinction matters: this is a duration call, priced like a long-duration bond re-rate, not a fundamental upgrade.
The raise landed three days after Simply Wall Street published two separate pieces arguing VRSN already trades above fair value on cash flow metrics. Wedbush's counter is implicit: a contractual monopoly on .com and .net registry operations earns a premium over what a standard DCF assigns a business growing revenue at 5.7% YoY. Both camps are looking at the same $308.72 stock and reaching opposite conclusions.
$800 Million in Free Cash Flow on $1.7 Billion Revenue Is Structural
VeriSign operates the .com and .net top-level domain registries under ICANN contract. TTM revenue of $1.7bn at 5.7% YoY growth converts to $800mn in FCF, a 47% margin most technology companies treat as a decade-away aspiration.
The ratio is structural, not cyclical. The registry business carries minimal variable cost; each domain renewal is near-pure margin above a fixed operating base. What Wedbush is effectively arguing is that the 28.2x forward P/E is not pricing in the contractual durability of those cash flows. The surprise: VRSN re-rates more like investment-grade infrastructure than a software stock when the discount rate shifts, which makes the PT move more rate-macro than company-specific. You will not read that angle on the wires.
Domain Count Is the One Number That Can Break This Thesis
VeriSign reports net domain name registrations each quarter. The global .com and .net base is the denominator for every renewal fee the company collects, and it is the variable neither Wedbush nor any DCF model controls. The domain name market has expanded at low single digits annually, supported by small-business and creator-economy formation. A reversal is not priced in at any multiple.
If registration volume decelerates materially, whether from slower website formation, small-business saturation, or alternative TLDs gaining ground, the recurring revenue base erodes regardless of ICANN pricing flexibility. Wedbush's target is defensible only if the domain base holds. The specific falsifier: two consecutive quarters of negative net registrations. That is when that multiple on a 5.7% grower becomes very difficult to defend. Watch Q3 earnings for the domain base figure before treating this PT raise as confirmed.
Generate a full fundamental breakdown of VeriSign at basisreport.com/stock/vrsn, or pressure-test the valuation assumptions with the DCF calculator.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Wedbush maintained its rating on VeriSign (VRSN) and raised its price target to $367.